Skip to main content
Fig. 2 | Hereditas

Fig. 2

From: SKA3 is a prognostic biomarker and associated with immune infiltration in bladder cancer

Fig. 2

Kaplan Meier survival curve assessed the relationship between SKA3 expression level and prognosis in Prognoscan. A, B OS (overall survival) and DSS (disease-specific survival) in cohort GSE13507 of bladder cancer. C OS in cohort GSE13213 of lung cancer. D RFS (relapse-free survival) in cohort GSE31210 of lung cancer. E OS in cohort GSE31210 of ovarian cancer. F DFS (disease-free survival) in cohort GSE14333 of colorectal cancer. G DSS in cohort GSE3499-GPL97 of breast cancer. H OS in cohort GSE4271-GPL97 of brain cancer cohort. I OS in cohort GSE19234 of skin cancer

Back to article page